CalciMedica, Inc.
CALC· Nasdaq
Filed Aug 12, 2025 · 10-Q · 43 days after period end · 0000950170-25-107334
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$5.96M | -$3.95M | -$6.30M | -$3.03M |
| EPS Diluted | -$0.40 | -$0.36 | -$1.11 | -$36.55 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CalciMedica, Inc. · CIK 1534133 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 12, 2025 · 43 d after period end